New Leadership Energizes NASP Board of Directors
Recently, at a significant gathering in Denver, the National Association of Specialty Pharmacy (NASP) announced a notable expansion in its leadership team. Scott Guisinger, the Board Chairman and Vice President of Pharmacy at Northeast Shared Services, shared the exciting news during the Annual Meeting & Expo.
Introducing New Board Members
This year, NASP welcomed four esteemed professionals to its Board of Directors, bringing a wealth of experience and dedication to the specialty pharmacy industry:
Meet the New Appointees
1. Juliana DeFrancis, RN, BSN from Lyceum Health, who serves as Vice President of Manufacturer Trade Relations & Brand Sourcing.
2. Jennifer Donovan, PharmD, RPh from Shields Health Solutions, taking on the role of Vice President of Clinical Services.
3. Richard Faris, PhD, MSc, RPh from PANTHERx Rare Pharmacy, holding the position of Chief Commercial and Clinical Officer.
4. Onisis Stefas, CEO of Vivo Health at Northwell Health, adds to the diverse range of expertise on the board.
Re-election of Experienced Directors
In addition to welcoming new members, several current directors were also re-elected for an additional three-year term. These experienced leaders include:
Continuing Leaders
- Natalie Bedford from McKesson
- Nick Calla, RPh, Esq from Orsini Specialty Pharmacy
- Thomas Cohn, MS from Asembia
- Erik Halstrom, MBA from Turning Point
- Kelli Heathman from BeOne Medicines USA
- Mike Nameth, RPh from Blink Health
- John Robicsek, MBA from Atrium Health, which is now part of Advocate Health
- Rebecca Shanahan, JD from Shanahan Capital Ventures, LLC
The NASP board's composition reflects the vibrant diversity that characterizes both the organization and the specialty pharmacy sector.
Enhancing Specialty Pharmacy's Role in Healthcare
During his address titled “There’s No Time Like Now,” Dr. Guisinger emphasized the importance of NASP members to reaffirm specialty pharmacy's crucial position within the healthcare delivery system. He advocated for innovation, unwavering advocacy, and an ongoing dedication to significantly improving patient outcomes across the board.
About NASP
The National Association of Specialty Pharmacy (NASP) operates as a non-profit trade organization under section 501(c)(6). It stands out as the only national group representing a comprehensive array of stakeholders within the specialty pharmacy domain. The mission of NASP is to empower these stakeholders to elevate the standard of patient care throughout the industry.
NASP champions a free market healthcare system, where all specialty pharmacies can compete fairly, ultimately benefiting the patients who rely on their services. The organization is committed to collaborating with stakeholders and policymakers to ensure that patients have unfettered access to life-saving medications and the comprehensive patient care services they deserve.
Representing a robust membership of over 3,500 individuals, NASP unites the collective voices of specialty pharmacy professionals across the United States, advocating for policies and practices that enhance patient care and outcomes.
Frequently Asked Questions
What is the significance of the NASP Annual Meeting & Expo?
The meeting serves as an important platform for networking, sharing innovations, and discussing the future of specialty pharmacy.
Who is the new Chairman of the NASP Board?
Scott Guisinger is the current Board Chairman, steering the organization towards its goals.
How many members does NASP currently have?
NASP boasts a membership that exceeds 3,500, comprising various stakeholders in the specialty pharmacy sector.
What are NASP's primary goals?
NASP aims to enhance patient care standards, represent industry stakeholders, and ensure access to essential medications.
What roles do the newly appointed board members hold?
The new board members hold key positions in their respective organizations, contributing to the growth and advocacy of specialty pharmacy.
